Prostate cancer affects the prostate, a walnut-size gland in men that surrounds the urethra and normally helps produce seminal fluid. Unlike other cancer types, prostate cancer sometimes grows very slowly. If it's an early-stage cancer, it may be safe to use "watchful waiting" or "active surveillance" to monitor the cancer and delay treatment unless it gets bigger or more threatening. Prostate cancer treatments include radiation, surgery, and hormone therapy, which can have side effects such as erectile dysfunction or incontinence.
Prostate Cancer News
WEDNESDAY, Sept. 17, 2014 (HealthDay News) — A blood test that measures DNA from a prostate cancer tumor could provide doctors with a better assessment of the state of a man’s disease, a new study suggests. If used routinely, this blood test could reveal when treatment for advanced prostate cancer stops working and actually begins [...]
Men with male pattern baldness may face a higher risk of developing an aggressive type of prostate cancer than men with no balding, a new study suggests.
MONDAY, Sept. 15, 2014 (HealthDay News) — An international team of scientists has identified 23 new genetic variants linked to a greater risk for prostate cancer. Although more research is needed, the researchers said their findings, which bring the total number of common gene variants associated with prostate cancer to 100, could help [...]
MONDAY, Sept. 8, 2014 (HealthDay News) — Men newly diagnosed with prostate cancer often turn first to testosterone-depleting therapies, since male hormones help prostate tumors grow. But, those therapies almost always fail over time as the tumor develops resistance, according to oncologists. Now, experts are issuing updated guidelines to help patients in this situation decide what to [...]
MONDAY, Sept. 8, 2014 (HealthDay News) — Monitoring early stage prostate cancer instead of treating it may not be appropriate for all patients, especially black men, a new study indicates. According to background information with the study, there is currently controversy among oncologists over the best way to handle early stage prostate cancer, with some experts [...]